These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3123423)

  • 1. Flecainide acetate: critical care administration guidelines.
    Senior S; Baessler C; Monzo M
    Heart Lung; 1988 Jan; 17(1):76-80. PubMed ID: 3123423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
    Chase SL; Sloskey GE
    Clin Pharm; 1987 Nov; 6(11):839-50. PubMed ID: 3119276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective dose of flecainide for arrhythmia in children].
    Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
    Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmias.
    Wang T; Siddoway LA; Thompson KA; Conard GJ; Bergstrand RH; Kvam D; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1988 May; 43(5):499-508. PubMed ID: 3130211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide: its value and danger.
    Malik R; Ellenbogen KA; Stambler BS; Wood MA
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide: evidence of non-linear kinetics.
    Boriani G; Strocchi E; Capucci A; Callivà R; Frabetti L; Ambrosioni E; Magnani B
    Eur J Clin Pharmacol; 1991; 41(1):57-9. PubMed ID: 1782978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anomalies of the T waves induced by flecainide].
    Stoltz JP; Weingrod M; Leroy G; Halphen C; Haïat R
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1009-12. PubMed ID: 3144249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 16. Flecainide acetate.
    Howland-Gradman J
    Crit Care Nurse; 1987; 7(2):28-9. PubMed ID: 3103982
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up.
    Facchini M; Varisco T; Bonazzi O; Priori SG; Songa V; Schwartz PJ
    Am Heart J; 1989 Jun; 117(6):1258-64. PubMed ID: 2499170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 20. Flecainide: a new antiarrhythmic agent.
    Nestico PF; Morganroth J
    Am Fam Physician; 1986 Nov; 34(5):197-200. PubMed ID: 2430440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.